This highly under-rated pharmaceutical stock breaking out this week from very narrow consolidation happening since past couple of months. Could break its ATH in this rally. Let's see.
Chart PatternsFundamental AnalysisTrend Analysis

Anche su:

Declinazione di responsabilità